help@researchreport.co.uk

Global and China Biomedicine Market 2012-2020: Market Size, Structure, Trends, Analysis and Forecast

  • Report ID : 100387
  • Category : Pharmaceuticals
  • Pages : 118
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allow Upto 5 User to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports
The  annual  growth  rate  of  world  biomedicine  market  has  been  outpacing  that  of  the  overall  pharmaceutical  market  in  recent  years  and  this  trend  will  continue  in  the  coming  years  with  a  steady  10.4%  growth  per  annum  by  2020.  In  particular,  China’s  biomedicine  market  is  expected  to  grow  at  an  even  higher  rate  (15%  annually)  over  the  forecast  2015-2020  period,  driven  by  increasing  and  aging  population,  government  initiatives  and  favorable  policies,  improving  level  of  biotech  and  innovation,  and  increasing  urbanization  as  well  as  household  income  in  China.

Global  and  China  Biomedicine  Market  2012-2020:  Market  Size,  Structure,  Trends,  Analysis  and  Forecast  reviews  the  worldwide  market  of  biological  medicines  and  reagents  with  Chinese  biomedicine  market  examined  in  detail  specifically.  With  global  economic,  demographic,  and  healthcare  profiles  reviewed  as  market  environments,  this  report  provides  market  trend  of  world  biomedicines  for  2012-2020,  market  structure  of  product  segments  (Therapeutic  Protein,  Antibody,  Vaccines,  Blood  Products,  and  Diagnostic  Reagent),  dynamics  of  biosimilar  segment,  geographic  spread  (North  America,  Europe,  Asia  Pacific  region,  Latin  America  and  the  rest  of  world),  development  highlights  in  global  biomedicines  market,  and  20  profiled  leading  biomedicine  manufacturers  in  the  world.  
Qualitative  market  analyses  for  Chinese  biomedicine  market  include  market  growth  drivers,  restraints  and  challenges,  emerging  market  opportunities,  and  competitive  landscape.  Based  on  biomedicine  type,  China’s  biomedicine  market  is  segmented  into  Therapeutic  Protein,  Antibody,  Vaccines,  Blood  Products,  and  Diagnostic  Reagent,  with  the  fast-growing  generic  biomedicines  highlighted  in  particular.  The  nation’s  market  is  also  analyzed  by  marketing  channel  and  by  region.  The  historic  performance  and  benchmarked  outlook  for  China’s  biomedicine  imports,  exports,  and  manufacturing  industry  are  also  provided  with  data  available  for  2010-2020  period.  The  major  biological  bases  and  clusters  in  China  are  revealed  and  32  Chinese  key  biomedicine  producers  are  profiled.


Companies  Mentioned
selected  global  companies:
Pfizer,  Inc.

Novartis  International  AG
Merck  &  Co.,  Inc.

F.  Hoffmann-La  Roche  AG
Sanofi  S.A.

Eli  Lilly  and  Company  
Selected  Chinese  companies:
Beijing  Tiantan  Biological  Products  Co.,  Ltd.

Shanghai  Kehua  Bio-engineering  Co.,  Ltd
Staidson  (Beijing)  Biopharmaceuticals  Co.,  Ltd.

Biotech  Pharmaceutical  Co.,  Ltd.  (BPL)
Innovent  Biologics,  Inc.

Zhuhai  Livzon  MAB  Biological  Technology  Company  Ltd.


Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.


Please Fill In The Customization Form With Your Requirements.


Help Center

Email Address : help@researchreport.co.uk

Help Center

Toll Free :+442037693786

More FAQ's